Auriga

A report from Auriga downgrades its rating from Buy to Hold and lowers its price target from $9 to $7 on MEMC Electronic Materials (NYSE: WFR). The report states, “MEMC's efforts to transform into a fully streamlined and integrated solar PV business (~2/3 of sales), already on a delayed schedule,...

A report from Auriga reiterates its Buy rating and raises its price target from $37 to $39 on Cavium Networks (NASDAQ: CAVM). The report states, “We are particularly enthusiastic about CAVM's long-term prospects in the micro basestation segment, as the concept of heterogeneous networks with...

A report from Auriga reiterates its Buy rating and lowers its price target from $78 to $70 on Computer Programs & Systems (NASDAQ: CPSI). The report states, “We are reiterating our BUY rating on Computer Programs & Systems (CPSI) following a weak quarter in which revenue and EPS fell short...

A report from Auriga reiterates its Hold rating and $73 price target on Heartware (NASDAQ: HTWR). The report states, “On Friday, Heartware (HTWR, HOLD) reported 3Q11 revenues of $21.3MM – modestly ahead of the $20.8MM street estimate and our $20.7MM estimate… Overall, it was a good quarter for...

Auriga has lowered the price target on Computer Programs & Systems (NASDAQ: CPSI) from $78 to $70 and maintains its Buy rating.

Auriga has raised the price target on Cavium Networks (NASDAQ: CAVM) from $37 to $39 and maintains its Buy rating.

Auriga has downgraded MEMC Electronic Materials (NYSE: WFR) from Buy to Hold and has lowered the price target from $9 to $7.

Auriga is out with its report today on eResearch (NYSE: ERT), reiterating Buy. In its report, Auriga writes, "We are reiterating our BUY rating on eResearch following Q3 results in which EPS met the consensus view while revenues beat modestly. Record bookings were a highlight of the quarter, and...

Auriga is out with its report today on Cerner (NASDAQ: CERN), raising its PT from $72 to $75. In its report, Auriga writes, "Cerner and privately held Epic dominate the healthcare IT market in our view. Meanwhile Cerner's strong medical device connectivity, while a lower margin business, leads the...

Auriga is out with its report today on Deckers Outdoor (NASDAQ: DECK), raising its PT from $115 to $125. In its report, Auriga writes, "We are increasing our PT to $125 from $115 to reflect our increased confidence that DECK could report upside in Q4 and into 2012." Auriga maintains Buy on DECK...

Auriga is out with its report today on PMC-Sierra (NASDAQ: PMCS), lowering its PT from $8 to $6.50. In its report, Auriga writes, "We maintain our Hold rating, but reduce our price target to $6.50 from $8 for PMC-Sierra as the company reported largely in-line 3Q11, but the 4Q11 guidance fell well...